Entera Bio
Entera Bio develops novel oral drugs therapeutics for the treatment of hypoparathyroidism.
Business Model:
Revenue: $353k
Employees: 11-50
Industries / Tags:
Detailed Entera Bio Information
Geographic Data
Address: Kiryat Hadassah Minrav Building, 5th Floor
City: Jerusalem
State: jerusalem district
Zip: 91220
Country: IL
Financial Info
Stage:
post ipo equity
Raised Last:
$14M
Raised Total:$24M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Entera Bio develops novel oral drugs therapeutics for the treatment of hypoparathyroidism.
Contact Phone:
Contact Email:
Entera Bio went public on 7/31/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/31/2020
Ticker Symbol:
ENTX
IPO Price:
$1.743262232577095/share
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
